Patent Strategy for a Korean Cosmetic Cream — Protecting Innovation Without Crossing Regulatory Lines
Context: turning a “cosmetic product” into a defensible IP asset
A Korean cosmetics company asked us to protect a newly developed functional cream intended for the Italian/EU market. The commercial goal was clear: launch fast, deter copycats, and create an IP position strong enough to support distribution and potential licensing.
The legal challenge was twofold. First, not every cosmetic formula is patentable: the invention must meet the classic patentability requirements (novelty, inventive step, industrial applicability) and the application must disclose the invention clearly enough to be reproduced by a skilled person. Second—and crucially—a patent filing is an IP step, not a “marketing authorization.” Even a perfectly drafted patent does not replace EU cosmetics compliance or allow medical-style claims.
Our work: patentable features, claim discipline, and a compliance-safe narrative
We approached the file as a combined IP + regulatory risk project.
On the patent side, we ran a targeted patentability and prior-art review to identify the elements that could realistically support inventive step: the composition logic (actives + ranges), stability/vehicle system, manufacturing parameters that create a reproducible structure, and performance indicators that can be measured and supported. We then built a claim strategy designed to survive scrutiny and remain enforceable, avoiding “marketing language” and focusing on technical features the patent office can examine.
At the same time, we kept the line between cosmetic positioning and medical/therapeutic territory clean. In Europe, “methods of treatment” are not patentable as such, and cosmetics advertising must not slide into medicinal claims. We therefore shaped the wording so the invention remained in the proper cosmetic domain, and we coordinated with the client to ensure that any external messaging (labels, brochures, website) would be supported by evidence and would not create avoidable regulatory exposure.
The result was a structured filing that protected the core technical concept while remaining realistic for examination, with built-in fallback positions and a specification supported by R&D documentation. In parallel, we aligned the client’s go-to-market path with the EU cosmetics framework: appointing the appropriate EU “Responsible Person,” building the Product Information File (PIF) and safety assessment workflow, handling CPNP notification steps, and ensuring that product claims and communications could be substantiated in line with EU standards.
In short, the client obtained not only a patent strategy, but an integrated approach: IP protection that increases leverageand compliance discipline that reduces predictable risk—so the product could scale in Italy/EU without being undermined by weak claims, avoidable objections, or regulatory missteps.
Confidentiality note: identifying details have been omitted/modified. Outcomes depend on individual circumstances and authority assessment.
